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Natural Killer Cells: Review
From No Receptors to Too Many
Lewis L. Lanier encode type II membrane glycoproteins of the C-type
DNAX Research Institute lectin superfamily (reviewed by Ryan and Seaman, 1997;
Department of Immunobiology Yokoyama and Seaman, 1993). Genes in the NKC are
901 California Avenue preferentially expressed by NK cells and these genes
Palo Alto, California 94304 can be divided into two subfamilies: NKR-P1, which
contains three homologous genes (NKR-P1A, B, and C)
(Giorda and Trucco, 1991; Giorda et al., 1992; Ryan et
Described more than 20 years ago based on their func- al., 1992, 1995; Yokoyama et al., 1991), and Ly49, which
tional ability to kill certain tumor cell targets (Herberman includes at least nine closely related members (Ly49A±
et al., 1975; Kiessling et al., 1975), natural killer (NK) cells Ly49I) (Brennan et al., 1996a; Chan and Takei, 1989;
have subsequently been implicated in innate immunity Mason et al., 1995; Smith et al., 1994; Stoneman et al.,
against viruses, intracellular bacteria, and parasites (re- 1995; Wong et al., 1991; Yokoyama et al., 1989, 1990)
viewed by Scott and Trinchieri, 1995). Like T cells, NK (Figure 1). Recently, a rat NKC has been found on chro-
cells mediate cell-mediated cytotoxicity and secrete a mosome 4, syntenic with mouse chromosome 6, and
diverse array of cytokines and chemokines. The mecha- rat homologs of the NKR-P1 and Ly49 genes are located
nism of NK cell recognition and the receptors involved in this region (Dissen et al., 1996). Consistent with their
in this process have proven elusive. However, recent C-type lectin structure, NKR-P1 proteins have been
studies are beginning to delineate this complex and shown to bind synthetic carbohydrates (Bezouska et al.,
sophisticated system. It is now clear that NK cells are 1994); however, physiological ligands have not been
regulated by a fine balance between positive and nega- identified. A NKR-P1 loss mutant generated from a rat
tive signals derived from membrane receptors that de- NK cell line was unable to kill certain murine tumor cell
termine their ability to mediate cytotoxicity and secrete targets, and this activity was restored by genetic trans-
cytokines in response to immune challenge. fection with NKR-P1A cDNA, implicating NKR-P1 in tar-
Unlike the situation with B and T cells, NK cell develop- get cell recognition and NK cell activation (Ryan et al.,
ment and function does not require gene rearrange- 1995).
ments (reviewed by Spits et al., 1995). Furthermore, it Ly49A (Chan and Takei, 1989; Yokoyama et al., 1989),
seems unlikely that a single ``NK receptor'' will be re- the first gene discovered in the Ly49 family and the best
sponsible for all of the diverse biological properties at- characterized, encodes a disulfide-bonded homodimer
tributed to these cells. Instead, NK cells likely use an that binds H-2Dd and Dk ligands (Daniels et al., 1994a;
array of different receptors to trigger their effector func- Kane, 1994). NK cells expressing the Ly49A receptor
tions, depending upon the nature of the target and the are unable to kill target cells expressing H-2Dd and Dk,
cytokines available in the local environment (reviewed
suggesting that interactions between the receptor and
by Lanier et al., 1997). In in vitro model systems, many
ligand transmit ``negative signals'' that inactivate NK
different ``costimulatory'' or ``adhesion'' molecules (e.g.,
cell function (Karlhofer et al., 1992). Similarly, Ly49G2
LFA-1, CD2, CD16, CD26, CD27, CD28, CD44, CD69,
has been shown to recognize H-2Dd and H-2Ld (MasonNKR-P1, DNAM-1, Ly6, 2B4, and others) have been
et al., 1995) and Ly49C appears to bind several differentshown to induce NK cell±mediated cytotoxicity and cy-
H-2 ligands, possibly including H-2d, H-2k, H-2b, and H-2stokine secretion (reviewed by Lanier et al., 1997). How-
(Brennan et al., 1994, 1996a). There is evidence for allelicever, the role of these receptors in NK cell responses in
polymorphism of the Ly49 genes and alternative splicingvivo against pathogens, transformed cells, or allogeneic
of the transcripts (Silver et al., 1996; Smith et al., 1994;grafts has not been defined.
Sundback et al., 1996). Additionally, each allele at aBased on the ability of NK cells to preferentially kill
given Ly49 locus can be regulated independently by ancertain tumors lackingmajor histocompatibility complex
as yet undefined mechanism (Held et al., 1995). All of(MHC) class I, the existence of an immune surveillance
the Ly49 receptors analyzed have been found on over-process for the elimination of host cells with abnormal
lapping subsets of NK cells in frequencies that varyor absent class I molecules was proposed (Karre et al.,
subtly in different mouse strains (Karlhofer et al., 1992;1986). Immunity against cells lacking MHC class I would
Mason et al., 1995, 1996; Stoneman et al., 1995; Yu etpotentially prevent pathogens (or transformed cells)
al., 1994).from escaping immune detection simply by disrupting
Humans have an NKC located on chromosome 12class I synthesis or transport. The ability of MHC class
p12.3±p13.1, syntenic with mouse chromosome 6 (Fig-I on target cells to prevent NK cell±mediated cytotoxicity
ure 1). Within this region are several genes of the C-typehas been validated in several experimental models, both
lectin superfamily encoding type II proteins that arepref-invivo and in vitro. Genes encoding theNK cell receptors
erentially expressed by NK cells and some T cells. Pres-for MHC class I have been cloned, the mechanisms of
ently only one human NKR-P1 gene (CD161) has beensignal transduction are being analyzed, and insights into
identified (Lanier et al., 1994). Like the rodent NKR-P1the physiological consequences of this process are
molecules, CD161 is expressed as a disulfide-bondedemerging.
homodimer on most NK cells and a subset of ``memory''
T cells (Lanier et al., 1994). Natural ligands of this recep-The NK Cell Complex
tor have not been identified, but interestingly cross-There is a cluster of genes on mouse chromosome 6,
in a region designated the NK cell complex (NKC), that linking of human NKR-P1 with monoclonal antibodies
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their class I ligands on targets. Cloning of the cDNAs
encoding these receptors (Colonna and Samaridis,
1995; D'Andrea et al., 1995; Wagtmann et al., 1995a)
revealed the existence of a family of genes, designated
the killercell inhibitory receptors (KIR) (Long et al., 1996),
on human chromosome 19 q13.4 (Baker et al., 1995).
Unlike the Ly49 or CD94/NKG2A receptors, KIR are type
I glycoproteins related to the immunoglobulin superfam-
ily (Colonna and Samaridis, 1995; D'Andrea et al., 1995;
Wagtmann et al., 1995a). More than 25 cDNA have been
identified that potentially encode KIR glycoproteins (re-
viewed by Lanier et al., 1997; Long et al., 1997). Pres-
ently, it is uncertain how much of this diversity is a result
of allelic polymorphism, alternative splicing of tran-
Figure 1. The NK Complex scripts, or distinct genes. However, results from geno-
Diagrammatic representation of the genes located in the human and mic Southern blot analysis are consistent with the exis-
mouse NK complex on chromosome 12 p12.3±p13.1 and chromo- tence of a small KIR gene family (Colonna and Samaridis,
some 6, respectively. The relative positions of the genes shown are 1995; D'Andrea et al., 1995; Wagtmann et al., 1995a).
not yet determined.
Of the KIR implicated as inhibitory receptors for MHC
class I ligands, three distinct protein isoforms have been
described (Figure 2). KIR involved in HLA-C recognition
can either inhibit or activate cytotoxicity mediated by are usually monomeric glycoproteins of z58 kDa con-
certain NK cell clones (Lanier et al., 1994; Poggi et al., taining two immunoglobulin-like domains (KIR-2D) in the
1996). extracellular region (Figure 2) (Colonna and Samaridis,
As yet, human homologs of the Ly49 genes have not 1995; D'Andrea et al., 1995; Wagtmann et al., 1995a).
been found. However, by using subtractive hybridization Bycontrast, KIR reactive with HLA-B arez70 kDa mono-
to isolate genes preferentially transcribed in human NK meric glycoproteins with three immunoglobulin-like do-
cells, a small family of five C-type lectin genes, desig- mains (KIR-3D) (Figure 2) (Colonna and Samaridis, 1995;
nated NKG2A±NKG2E, have been identified in the hu- D'Andrea et al., 1995; Wagtmann et al., 1995b). Recent
man NKC (Adamkiewicz et al., 1994; Houchins et al., studies suggest that certain KIR reactive with HLA-A
1991; Yabe et al., 1993), and these molecules may pro- ligands possess three immunoglobulin domains in the
vide immune functions similar to Ly49. The NKG2 genes extracellular region (Dohring and Colonna, 1996; Pende
differ in both the extracellular and cytoplasmic domains, et al., 1996) and are expressed on the cell surface as
suggesting possible heterogeneity in ligand binding and disulfide-linked homodimers composed of two z70 kDa
signal transduction. While the Ly49 receptors are disul- subunits (Pende et al., 1996) (Figure 2).
fide-bonded homodimers, the NKG2 glycoproteins form Although a murine KIR has not been identified, two
disulfide-bonded heterodimers with another glycopro- mouse genes related to human KIR, designated gp49A
tein designated CD94 (Brooks et al., 1997; Carretero et and gp49B, have been cloned from murine mast cells
al., 1997; Lazetic et al., 1996). CD94 is encoded by a (Arm et al., 1991; Castells et al., 1994). Like the KIR-2D
single gene of the C-type lectin superfamily (Chang et molecules, the gp49 glycoproteins contain two immuno-
al., 1995) located within the human NKC (Renedo et al., globulin-like domains in the extracellular region and the
submitted). Monoclonal antibodies against CD94 have gp49B1 receptor is able to inhibit mast cell degranula-
been shown to affect NK cell recognition of target cells tion when it is coligated together with the high affinity
transfected with several HLA-A, B, and C genes (Moretta IgE receptor (Katz et al., 1996). Recent studies indicate
et al., 1994; Phillips et al., 1996; Sivori et al., 1996). that all mouse NK cells express gp49B1 (Wang et al.,
Therefore, while the Ly49 and CD94/NKG2 receptors 1997), and transfection of mouse NK cells with chimeric
are not strictly structural homologs, they may have receptors containing the extracellular domain of human
evolved to serve a similar function in rodents and hu- KIR linked to the cytoplasmic domain of gp49B1 has
mans, respectively. shown that the gp49B1 cytoplasmic domain is capable
of inhibiting NK cell±mediated cytotoxicity (Rojo et al.,
KIR 1997a). However, gp49B1 is probably not the murine
The existence of human inhibitory NK cell receptors equivalent of human KIR because a human gene with
for polymorphic MHC class I molecules was predicted greater homology to gp49 than KIR has recently been
based on the observation that NK cells killed HLA class identified (Rojo et al., 1997a). Furthermore, it seems un-
I±deficient B lymphoblastoid cell lines, but did not lyse likely that MHC class I will serve as the ligand for the
these target cells when transfected with certain HLA gp49 receptors (Rojo et al., 1997a; Wang et al., 1997).
class I genes (Shimizu and DeMars, 1989; Storkus et al.,
1989). Membrane glycoproteins on NK cells involved in
the recognition of HLA-A (Dohring et al., 1996; Pende NK Recognition of MHC Class I
The Ly49 receptors recognize polymorphic determi-et al., 1996), HLA-B (Litwin et al., 1994), and HLA-C
(Moretta et al., 1993) were subsequently identified by nants of H-2 that map to the a1/a2 domain of the class
I heavy chain (Karlhofer et al., 1992; Sentman et al.,using monoclonal antibodies that disrupted interactions
between the inhibitory receptors on the NK cells and 1994). The extracellular domain of H-2Dd is sufficient to
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Figure 2. Inhibitory Receptors for MHC
Class I
Diagrammatic representation of the Ly49,
CD94-NKG2A, and KIR isoforms implicated
as inhibitory receptors for MHC class I. A
common feature in all of these receptors is
ITIM sequences in the cytoplasmic domains.
Disulfide bonds between the receptor sub-
units are indicated (C-C). Ly49 and CD94/
NKG2Aare type II proteins of theC-type lectin
superfamily, whereas the KIR are type I pro-
teins of the immunoglobulin superfamily.
confer target cell protection against NK cell lysis, as ligands have confirmed the specificity of this interaction
(Dohring and Colonna, 1996; Fan et al., 1996; Wagtmanndemonstrated by experiments using H-2Dd tethered to
the membrane of target cells via a glycosylphosphatidyl- et al., 1995b) and demonstrate that the receptor and
ligand bind with a 1:1 stochiometry (Fan et al., 1996).inositol anchor (Sentman et al., 1996). While the affinity
of the Ly49 receptors may be influenced by thepresence Carbohydrates on the HLA class I molecules are not
required for interaction with KIR (Fan et al., 1996; Gum-of carbohydrate on the class I molecule (Brennan et al.,
1995; Daniels et al., 1994b), it seems very unlikely that perz et al., 1995).
As yet, no consensus has emerged on the role of b2-carbohydrates alone can explain the H-2 allele specific-
ity of these receptors. An intact H-2 class I trimer (com- microglobulin and peptides in KIR recognition. Mandel-
boim et al. (1996b) have suggested that the two-immu-posed of a heavy chain, b2-microglobulin, and a bound
peptide) is required for functional interactions with noglobulin domain KIR can recognize HLA-C ligands in
the absence of bound peptides, whereas studies of aLy49A (Correa and Raulet, 1995; Orihuela et al., 1996).
Peptides are required to generate a stable H-2 molecule three-immunoglobulin domain KIR demonstrate that a
peptide bound to the HLA-B*2705 class I heavy chainwith the proper conformation; however, Ly49 is unable
to discriminate between different peptides within the is necessary (Malnati et al., 1995; Peruzzi et al., 1996b).
In the latter case, residues at positions 7 and 8 in theMHC complex (Correa and Raulet, 1995; Orihuela et
al., 1996). Preliminary findings indicate that both the peptide influence the interaction between the class I
complex and the KIR (Peruzzi et al., 1996a). Althoughcarbohydrate recognition domain and the stalk region
of the Ly49 receptor are necessary for ligand binding different peptides may affect the conformation of the
(Brennan et al., 1996b).
Like Ly49, KIR recognize a region in the a1 domain
of the HLA class I heavy chain (Biassoni et al., 1995;
Cella et al., 1994; Colonna et al., 1993; Gumperz et al.,
1995; Mandelboim et al., 1996b). The three-immuno-
globulin domain KIR designated NKB1 recognizes the
HLA-Bw4 motif, which is conferred by amino acids
77±83 in the a1 domain of certain HLA-B heavy chains
(Gumperz et al., 1995) (Figure 3). Interaction between
this three-immunoglobulin domain KIR and HLA-B*5101
(a Bw4 allele) has been confirmed by direct binding
assays using a recombinant KIR fusion protein (Rojo
et al., 1997b). Other three-immunoglobulin domain KIR,
recognized by the 5.133 and Q66 monoclonal antibod-
ies, recognize HLA-A3 (Figure 3), although the structural
properties of this specificity have not been well charac-
terized (Dohring et al., 1996; Pende et al., 1996). The
Figure 3. HLA Class I Specificity of KIR
two-immunoglobulin domain KIR recognize a polymor-
Diagrammatic representation of the KIR reactive with HLA-A, B, andphism at positions 77 and 80 of the HLA-C heavy chain
C ligands. The two-immunoglobulin domain KIR identified using the
(Colonna et al., 1993). KIR reactive with the EB6 (Moretta EB6 or HP-3E4 monoclonal antibodies recognizes HLA-Cw4 and
et al., 1993) or HP-3E4 (Lanier et al., 1995) monoclonal other HLA-C alleles possessing asparagine at residue 77 and lysine
at residue 80 in the HLA-C heavy chain. The two-immunoglobulinantibodies recognize HLA-Cw4 and related alleles (pos-
domain KIR identified using the GL183 monoclonal antibody recog-sessing asparagine at residue 77 and lysine at residue
nizes HLA-Cw3 and other HLA-C alleles possessing serine at residue80), whereas KIR detected with the GL183 monoclonal
77 and asparagine at residue 80 in the HLA-C heavy chain. Theantibody (Moretta et al.,1993) bind HLA-Cw3 and related
three-immunoglobulin domain KIR NKB1, identified using mono-
alleles (serine at residue 77 and asparagine at residue clonal antibody DX9, binds HLA-B alleles possessing the Bw4 motif.
80) (Figure 3). Direct binding studies using soluble re- The three-immunoglobulin domain KIR NKAT4, identified by the
monoclonal antibody 5.133, recognizes HLA-A3.combinant two-immunoglobulin domain KIR and HLA-C
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class I molecule near the binding site of KIR, present As yet, little is known about the tyrosine kinases that
phosphorylate the ITIMs of the NKG2A, KIR, and Ly49results indicate that KIR do not discriminate between
``self'' and ``foreign'' peptides, making the physiological receptors and the critical substrates of the tyrosine
phosphatases, although these may likely depend uponrole of peptides in NK function uncertain.
The HLA class I specificity of the human CD94/NKG2 the particular positive signaling receptor that initially
activates the NK cell. A potential role for the lck srcreceptors has not as yet been examined in detail. How-
ever, it appears that these receptors are more promiscu- family tyrosine kinase in KIR function is suggested by
experiments showing that overexpression of lck in NKous than the KIR (Lazetic et al., 1996; Phillips et al., 1996;
Sivori et al., 1996). CD94/NKG2 receptors can affect cells enhances KIR phosphorylation (Binstadt et al.,
1996). Studies have also indicated that a critical sub-recognition of many, but not all, HLA-A, B, and C alleles
(Phillips et al., 1996; Sivori et al., 1996). Unlike KIR, these strate of the SHP-1 phosphatase recruited by KIR recep-
tors is the p36 adapter protein (Valiante et al., 1996),receptors do not recognize the polymorphism defined
by residues 77 and 80 in the HLA-C molecules and they previously implicated in TCR and FcR signal transduc-
tion (Galandrini et al., 1996; Motto et al., 1996; Sieh etare unable to distinguish between HLA-Bw4 and HLA-
Bw6 alleles (Phillips et al., 1996). Moreover, there is as al., 1994).
Certain isoforms of the KIR, Ly49, and NKG2 familyyet no direct evidence that CD94/NKG2 heterodimers
bind to class I molecules. They could conceivably func- lack ITIMs in their cytoplasmic domains, and evidence
is accumulating to indicate that these receptors maytion as coreceptors involved in signaling, rather than
directly binding class I molecules (Lazetic et al., 1996; activate, rather than inhibit, T and NK cell proliferation
and cytotoxicity (Biassoni et al., 1996; Bottino et al.,Phillips et al., 1996).
1996; Houchins et al., 1997; Mandelboim et al., 1996a;
Mason et al., 1996). As yet, little is known about theSignal Transduction and Inhibitory Receptors
Cellular responses are often controlled by the opposing biochemical basis of this activity. It is unclear whether
these molecules are sufficient to stimulate effector func-actions of tyrosine kinases that activate and tyrosine
phosphatases that terminate signaling (Thomas, 1995). tion directly or whether they serve as costimulators
working in cooperation with other, as yet unidentified,For example, coligation of the immunoglobulin recep-
tors and FcgRIIB on B cells stimulate the tyrosine ki- activating receptors.
nases that phosphorylate the intracytoplasmic portion
of FcgRIIB, which in turn recruits the SHP-1 phospha-
Educating an NK Celltase that terminates immunoglobulin signal transduction
The KIR, CD94/NKG2A, and Ly49 receptors are ex-(D'Ambrosio et al., 1995). Molecular analysis of several
pressed on overlapping subsets of NK cells. This ismembrane receptors with inhibitory function revealed a
advantageous in that it allows the host immune systemcommon sequence I/VxYxxL/V (the immune receptor
to detect cells that have lost the expression of a singletyrosine-based inhibitory motif [ITIM]), which binds the
allele at only one MHC class I locus. However, it requiresSHP-1 tyrosine phosphatase and halts positive signals
a positive selection process during development to en-transduced via other receptors (Scharenberg and Kinet,
sure that all NK cells will express at least one inhibitory1996). The two-immunoglobulin domain and three-
receptor that can bind to a self class I molecule. Studiesimmunoglobulin domain KIR isoforms with a long cyto-
of this process are complicated by the fact that a singleplasmic tail possess two ITIMs, separated by 26±28
NK cell clone can simultaneously express multiple Ly49amino acids (Colonna and Samaridis, 1995; D'Andrea et
receptors in mouse and several KIR and/or CD94/NKG2al., 1995; Wagtmann et al., 1995a). Studies from several
receptors in man. Furthermore, certain KIR or Ly49 iso-groups have recently demonstrated that activation of
forms are expressed in hosts who do not possess rele-NK cells results in tyrosine phosphorylation of the KIR
vant ligands for these receptors (e.g., Ly49A, an H-2dITIMs, recruitment of SHP-1 (and possibly SHP-2), and
receptor, is expressed in B6 mice [Dorfman and Raulet,inhibition of NK cell±mediated cytotoxicity (Binstadt et
1996; Karlhofer et al., 1992] and NKB1 KIR, an HLA-al., 1996; Burshtyn et al., 1996; Campbell et al., 1996;
Bw4 receptor, is expressed in HLA-Bw6 homozygousOlcese et al., 1996). Like their function in NK cells, KIR
individuals [Gumperz et al., 1996]). Although these ob-can negatively regulate signals initiated in T cells via
servations suggest that the expression of Ly49 or KIRthe T cell receptor (TCR) by recruitment of SHP-1 (Fry
receptors is not strictly ligand induced or dependent,et al., 1996).
the MHC haplotype of the host can in fact influence theThe NKG2A receptor also has two ITIMs in the cyto-
level of Ly49 receptor expression and the function ofplasmic domain (Houchins et al., 1997; Lazetic et al.,
these molecules. Studies of B6 mice expressing an1996), and studies using chimeric receptors show that
H-2Dd transgene indicate that the transgenic mice doNKG2A ITIMs can recruit SHP-1 and inhibit NK cell±
not kill H-2Dd-bearing targets, whereas NK cells frommediated cytotoxicity (Houchins et al., 1997). Many of
normal B6 mice do lyse these cells (Olsson et al., 1995).the Ly49 glycoproteins have a single ITIM (reviewed by
Similarly, NK cells arising from bone marrow progenitorsRyan and Seaman, 1997), but since Ly49 receptors are
transplanted into an allogeneic recipient are unable todisulfide-linked homodimers this would provide for two
lyse the host (Sykes et al., 1993). Cell surface expressionITIMs per receptor. Negative signaling by the Ly49 re-
of Ly49A on the NK cells in these H-2Dd transgenic miceceptors and murine gp49B1, which has two ITIMs in its
and bone marrow chimeras are present at much lowercytoplasmic domain,also probably involves SHP-1 (Katz
levels than in normal B6 mice, indicating that an activeet al., 1996; Nakamura et al., 1997; Olcese et al., 1996;
Rojo et al., 1997a). process is involved (Olsson et al., 1995; Sykes et al.,
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